Winrevair 90 MG kit
Ended Awarded Last action
- Contract number
- 36C24526N0258
- Awardee
-
Merck Sharp & Dohme LLC UEI FCFDA78HKKG2
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,391
Award facts
- Contract value 100% obligated
- $21,390.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
Merck Sharp & Dohme LLC was awarded a delivery order valued at $21,390.85 on January 20, 2026, for WINREVAIR 90 mg kits under the Department of Veterans Affairs' Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). This award utilizes a firm fixed price structure with performance concluding by January 22, 2026, and delivery to occur in Bartlett, Tennessee. The delivery order was not subject to any small business set-aside designation. WINREVAIR (sotatercept-csrk) is a specialty therapeutic indicated for pulmonary hypertension treatment, supporting the VA's pharmaceutical supply chain across its Veterans Integrated Service Networks.
This delivery order is issued under the broader $5.84 billion FSS-61-IB contract between the Department of Veterans Affairs and Merck, which was awarded June 1, 2025, with performance extending through May 31, 2030. Merck has served as a critical pharmaceutical supplier to the VA and multiple federal agencies, including the Centers for Disease Control and Prevention, Department of Health and Human Services, and Department of Defense, with an extensive portfolio of vaccine and drug procurement contracts. The short completion timeline for this delivery order reflects the urgent healthcare needs within the Veterans Integrated Service Network 5, ensuring timely access to this specialized pulmonary hypertension medication for eligible veterans.
Quick answers
Who was awarded contract 36C24526N0258?
36C24526N0258 was awarded to Merck Sharp & Dohme LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on January 20, 2026.
How much is contract 36C24526N0258 worth?
The government has obligated $21,391 on 36C24526N0258.
Is contract 36C24526N0258 an order under another contract?
Yes. 36C24526N0258 is a delivery order under 36F79725D0146, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24526N0258 competed?
The extent of competition for 36C24526N0258 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award